• Home
  • RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.

Author List
Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS
Publication
Nature genetics
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1430164
Publication Year
2002
PubMed ID
12415269
Publication Title
Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet. 2002 Dec; 32(4):581-3.